Risk of Sudden Death in a General Unbiased Epidemiological Cohort of Sarcoidosis

C Anwar A Chahal1,2,3,4, Peter A Brady1,5, Leslie T Cooper6

  • 1Mayo Clinic College of Medicine and Science Mayo Clinic Rochester MN.

Insights

This study found no increased risk of sudden cardiac death (SCD) in people with sarcoidosis compared to the general population. While nocturnal deaths were more frequent in sarcoidosis patients, the difference was not statistically significant.

Area of Science:

  • Cardiology
  • Pulmonology
  • Epidemiology

Background:

  • Sarcoidosis is an inflammatory granulomatous disease of unknown etiology affecting multiple organ systems.
  • Cardiovascular involvement in sarcoidosis is linked to increased risk of sudden cardiac death (SCD).
  • The overall risk of SCD in the general sarcoidosis population remains unclear.

Purpose of the Study:

  • To investigate and compare the risk of sudden cardiac death (SCD) in individuals diagnosed with sarcoidosis versus a matched general population.
  • To analyze mortality patterns, including SCD, within a population-based cohort of sarcoidosis patients.

Main Methods:

  • A population-based cohort study utilized data from January 1, 1976, to December 31, 2013.
  • 345 incident sarcoidosis cases were age- and sex-matched with general population comparators.
  • Mortality data, including cause and timing of death, were manually adjudicated for SCD events; Cox models were employed for comparisons.

Main Results:

  • The incidence rate of SCD in the sarcoidosis cohort was 192 per 100,000 person-years, compared to 155 in the matched general population (Hazard Ratio [HR] 1.28, 95% CI 0.52-3.17).
  • No statistically significant difference in SCD risk was observed between sarcoidosis patients and comparators.
  • A higher frequency of nocturnal deaths was noted in the sarcoidosis group (HR 3.76), though this finding was not statistically significant.

Conclusions:

  • This population-based study indicates that sarcoidosis does not confer an increased risk of sudden cardiac death compared to matched controls.
  • Further research may be warranted to explore the observed trend of increased nocturnal deaths in sarcoidosis patients.

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
584
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
315
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
248
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
29
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
123
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
230